Poor solubility can reduce active availability
Many oil-soluble compounds do not mix well with digestive fluids. This can limit dissolution and create inconsistent absorption.
Bioavailability describes the proportion of an active ingredient that reaches circulation and becomes available for the body to use.
An ingredient may contain the correct labeled potency but still perform inefficiently if it dissolves poorly, breaks down during digestion, or is not absorbed effectively.
Many oil-soluble compounds do not mix well with digestive fluids. This can limit dissolution and create inconsistent absorption.
Smaller delivery structures create greater surface area and may help active ingredients disperse more effectively in digestive environments.
Smaller delivery structures can distribute more evenly throughout compatible liquid and solid formulations.
Reducing particle size increases the available surface area of the active delivery system.
Controlled particle distribution supports consistent active concentration across the finished batch.
Properly designed delivery systems can help reduce settling, separation, and inconsistent product appearance.
Particle size, distribution, stability, potency, and application performance should be evaluated using appropriate technical testing rather than relying only on marketing terminology.
Learn how particle size, ingredient uptake, and digestive processing can influence delivery-system performance.
Speak with our team about particle size, formulation compatibility, nano powders, liquid delivery systems, samples, and technical documentation.